10-KCTMXCIK 0001501989

CytomX Therapeutics, Inc.

Name: SEC EDGAR filing 0001193125-26-107146
Creator: CytomX Therapeutics, Inc.
License: https://www.usa.gov/government-works

Annual report (10-K) filed March 16, 2026.

Comprehensive annual report filed by U.S. public companies, including audited financial statements, MD&A, and risk factors.

Read the filing on SEC.gov All documents in this filing

New to the 10-K? What it is and how to read one

Filing facts

Accession number: 0001193125-26-107146
Filer: CytomX Therapeutics, Inc.
Ticker: CTMX
CIK: 0001501989
Form type: 10-K
Form description: Annual report
Filed at: March 16, 2026
Period of report: December 31, 2025
Industry: SIC 2834Pharmaceutical Preparations
Filing size: 16.0 MB
Last verified: August 26, 2026SecFilingDex pulls from EDGAR with daily cadence

More filings from CytomX Therapeutics, Inc.

See all 43 filings from CytomX Therapeutics, Inc. →

Provenance

Authoritative source — SEC EDGAR

https://www.sec.gov/Archives/edgar/data/1501989/000119312526107146/0001193125-26-107146-index.htm ↗

Filer's full EDGAR submission history

EDGAR · CytomX Therapeutics, Inc. (0001501989) ↗

SecFilingDex republishes SEC EDGAR data with provenance. EDGAR is the authoritative source. SecFilingDex is independent and not affiliated with the U.S. Securities and Exchange Commission. Nothing on this page constitutes investment, legal, tax, or other professional advice.